“Acquired CD20 Loss as a Mechanism of Resistance to Mosunetuzumab in Relapsed Follicular Lymphoma ” (2026) Mediterranean Journal of Hematology and Infectious Diseases, 18(1), p. e2026014. doi:10.4084/MJHID.2026.014.